Clinical Trials Browser

Unknown × Stomach Neoplasms × trifluridine tipiracil drug combination × Clear all

NCT05029102 2024-02-12

TAS-102 and Anlotinib in ≥3 Lines mGC

Phase 2 Unknown

Gastrointestinal

Stomach Neoplasms